RUNBEN BIOTECHNOLOGY (603193.SS)
CNY 23.56
(-1.01%)
CNY 23.56
(-1.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.03 Billion | 856.08 Million | 582.14 Million | 442.82 Million | 278.63 Million |
| Cost of Revenue | 450.92 Million | 392.15 Million | 273.33 Million | 210.2 Million | 127.92 Million |
| Gross Profit | 582.02 Million | 463.93 Million | 308.81 Million | 232.62 Million | 150.7 Million |
| Operating Expenses | 317.41 Million | 282.44 Million | 170.34 Million | 119.84 Million | 100.72 Million |
| Selling, General and Administrative Expenses | 282.4 Million | 223.81 Million | 120.48 Million | 81.21 Million | 81.49 Million |
| Research and Development Expenses | 24.3 Million | 19.51 Million | 13.6 Million | 10.71 Million | 7.81 Million |
| Other Expenses | 3.3 Million | -2.13 Million | -6.81 Million | 1.1 Million | 42.67 Thousand |
| Cost and Expenses | 768.33 Million | 674.6 Million | 443.68 Million | 330.05 Million | 228.65 Million |
| Operating Income | 264.61 Million | 185.79 Million | 140.88 Million | 110.17 Million | 41.69 Million |
| Interest Expense | 353.46 Thousand | 857.2 Thousand | 1.61 Million | 34.59 Thousand | 1.82 Million |
| Income Tax Expense | 41.89 Million | 28.22 Million | 20.98 Million | 15.52 Million | 6.06 Million |
| Earnings before Tax | 267.92 Million | 188.27 Million | 141.63 Million | 110.24 Million | 41.74 Million |
| Net Income | 226.02 Million | 160.04 Million | 120.64 Million | 94.71 Million | 35.67 Million |
| Earnings Per Share Basic | 0.64 | 0.40 | 0.30 | 0.23 | 0.70 |
| Earnings Per Share Diluted | 0.64 | 0.40 | 0.30 | 0.23 | 0.70 |
| Weighted Average Shares Outstanding | 353.16 Million | 404.59 Million | 404.59 Million | 404.59 Million | 404.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 353.16 Million | 404.59 Million | 404.59 Million | 404.59 Million | 404.59 Million |
| Gross Margin | 0.56 | 0.54 | 0.53 | 0.53 | 0.54 |
| EBIT Margin | 0.28 | 0.25 | 0.27 | 0.28 | 0.23 |
| Profit Margin | 0.22 | 0.19 | 0.21 | 0.21 | 0.13 |
| EBITDA | 290.05 Million | 209.27 Million | 152.69 Million | 118.83 Million | 57.99 Million |
| Earnings Before Tax Margin | 0.26 | 0.22 | 0.24 | 0.25 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 293.48 Million | 571.3 Million | 166.68 Million | 209.42 Million | 1.03 Billion | 244.37 Million |
| Cost of Revenue | 124.52 Million | 236.47 Million | 73.84 Million | 89.52 Million | 450.92 Million | 103.96 Million |
| Gross Profit | 168.96 Million | 334.83 Million | 92.83 Million | 119.9 Million | 582.02 Million | 140.41 Million |
| Operating Expenses | 88.49 Million | 178.78 Million | 65.23 Million | 80.65 Million | 330.69 Million | 66.38 Million |
| Selling, General and Administrative Expenses | 114.68 Million | 169.61 Million | 57.44 Million | 53.44 Million | - | 69.62 Million |
| Research and Development Expenses | 9.85 Million | 7.52 Million | 6.88 Million | 7.43 Million | - | 6.22 Million |
| Other Expenses | -36.03 Million | -1.64 Million | 5.01 Million | 3.02 Million | 3.3 Million | 235.62 Thousand |
| Cost and Expenses | 213.02 Million | 415.26 Million | 139.07 Million | 170.17 Million | 781.61 Million | 170.34 Million |
| Operating Income | 93.62 Million | 156.04 Million | 35.02 Million | 48.21 Million | 264.61 Million | 75.09 Million |
| Interest Expense | 35.9 Thousand | 31 Thousand | 38.12 Thousand | 53.28 Thousand | 256.3 Thousand | 42.24 Thousand |
| Income Tax Expense | 12.7 Million | 25.37 Million | 4.56 Million | 5.94 Million | 41.89 Million | 14.06 Million |
| Earnings before Tax | 93.56 Million | 169.92 Million | 40.04 Million | 51.23 Million | 267.92 Million | 75.32 Million |
| Net Income | 80.85 Million | 144.55 Million | 35.47 Million | 45.29 Million | 226.02 Million | 61.26 Million |
| Earnings Per Share Basic | 0.20 | 0.36 | 0.09 | 0.12 | - | 0.15 |
| Earnings Per Share Diluted | 0.20 | 0.36 | 0.09 | 0.12 | - | 0.15 |
| Weighted Average Shares Outstanding | 404.59 Million | 404.59 Million | 394.13 Million | 389.65 Million | 353.16 Million | 404.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 404.59 Million | 404.59 Million | 394.13 Million | 389.65 Million | 353.16 Million | 404.59 Million |
| Gross Margin | 0.58 | 0.59 | 0.56 | 0.57 | 0.56 | 0.57 |
| EBIT Margin | 0.32 | 0.28 | 0.26 | 0.26 | - | 0.31 |
| Profit Margin | 0.28 | 0.25 | 0.21 | 0.22 | 0.22 | 0.25 |
| EBITDA | 93.59 Million | 161.28 Million | 43.22 Million | 53.53 Million | - | 75.25 Million |
| Earnings Before Tax Margin | 0.32 | 0.27 | 0.21 | 0.23 | 0.26 | 0.31 |
HONASA
603991
AVAP
FPP
MAS
MIRI